Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02435082 · ClinicalTrials.gov registry record

Vascular Assessment of Regulation Index Arrays Registry

A clinical trial of Concussion, sponsored by NeuroChaos Solutions.

Completed
Registry status
13
Enrollment target
1
Study location

NCT02435082: Completed study of Concussion, sponsored by NeuroChaos Solutions.

NCT02435082 is a study of Concussion that has completed, run by NeuroChaos Solutions. The registered enrollment target is 13 participants, below the 144-participant average among 9 other Concussion trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02435082, a study of Concussion, has completed, sponsored by NeuroChaos Solutions.

COMPLETED
Registry status
13 participants
Enrollment target
1
Study location

Study Summary

The objective of this patient registry is to collect and analyze physiological data associated with baseline and brain injury identified in standard clinical practice (Normal Values, Recovery Curves, Correlation between Symptoms and Other Tests, NCI Index), and to assess health economics.

Primary Outcome

Patient Neurovascular Complexity Index (NCI) will be measured

Conditions Studied

Study Locations (1)

Texas

  • SportsSafe - Austin

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2015-04
Est. Completion 2016-05
NeuroChaos Solutions

1 total trials

What the finished NCT02435082 record still lists

NCT02435082 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 144-participant average among 9 other Concussion trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Concussion appearing as the primary indexed condition, and to 0 interventions.

NCT02435082 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT02435082 about?

NCT02435082 is a clinical study titled "Vascular Assessment of Regulation Index Arrays Registry". The objective of this patient registry is to collect and analyze physiological data associated with baseline and brain injury identified in standard clinical practice (Normal Values, Recovery Curves, Correlation between Symptoms and Other Tests, NCI Index), and to assess health economics.

What is the current status of trial NCT02435082?

This trial is currently completed. The enrollment target is 13 participants. The study started on 2015-04. Estimated completion is 2016-05.

What conditions does trial NCT02435082 study?

This clinical trial studies the following conditions: Concussion.

Who is sponsoring clinical trial NCT02435082?

This trial is sponsored by NeuroChaos Solutions, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02435082 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Concussion

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02435082's enrollment target sits among peer trials

13 10th of 9 the lowest of 9 other Concussion trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Concussion trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02435082, the US trial registry maintained by the National Library of Medicine. NCT02435082 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.